Skip to content
DraconiticResearch
Search Sources API
201,818 studies31 sourcesUpdated 27 min ago
Peer-reviewedCC BY-NC-ND 4.0Otolaryngology--Head and Neck Surgery

Clinic‐Based Transnasal Marsupialization for the Treatment of Congenital Dacryocystocele

6 affiliations
  1. 1Department of Anesthesiology Université de Montréal Montreal Quebec Canada
  2. 2Department of Ophthalmology Université de Montréal Montreal Quebec Canada
  3. 3Centre Hospitalier Universitaire Sainte‐Justine Université de Montréal Quebec Canada
  4. 4Department of Surgery, Division of Otorhinolaryngology Centre Hospitalier Universitaire Sainte‐Justine Montreal Quebec Canada
  5. 5Department of Surgery, Division of Ophthalmology Centre Hospitalier Universitaire Sainte‐Justine Montreal Quebec Canada
  6. 6Department of Otolaryngology & Communication Enhancement Boston Children's Hospital, Harvard Medical School Boston Massachusetts USA

Abstract

Objective: To evaluate the feasibility and outcomes of endoscopic intranasal marsupialization as treatment for congenital dacryocystocele, performed under topical anesthesia in a clinical setting.

Study Design: A retrospective review was conducted at a tertiary pediatric care hospital spanning from 2014 to 2024.

Setting: 23 infants under 1 year of age who underwent marsupialization under topical anesthesia for the treatment of a dacryocystocele were identified and their medical records were analyzed. No control group was used for this study.

Methods: Through a review of patient's medical files, the surgical technique used for cases of marsupialization under topical anesthesia in our medical center was documented and described.

Results: The primary outcome was the success rate of marsupialization procedures under topical anesthesia, defined as nonrecurrence. Secondary outcomes comprised periprocedural and postprocedure complications. The age of the patients at diagnosis ranged from 7.1 to 16.4 days. Among the 23 patients, 19 (83%) had previously failed conservative treatment before undergoing surgical intervention. Two patients (9%) experienced recurrent dacryocystocele. There were no perioperative or postoperative complications observed. Following the procedure, the most prevalent persistent symptom was nasal congestion, observed in 4 patients (17%). The mean time to treatment was 4.4 days and the overall hospital duration post‐procedure was 0.4 days.

Conclusion: This study underscores the efficacy and safety of clinic‐based endoscopic intranasal marsupialization for treating dacryocystocele. This approach expedites surgical care, eliminates the requirement for general anesthesia and allows a reduced hospital stay, making it a favorable treatment option in clinical practice.

Related

  1. TeleBACK clinical trial: comparing the effectiveness of telerehabilitation and in-clinic physical therapy for patients with chronic low back pain - protocol for a multicentre, pragmatic, individually randomised group treatment trial.
    Kevin H McLaughlin, Julie M Fritz, Kate I Minick +9
    BMJ openPeer-reviewedCC BY-NCFull textPharmacology & toxicologyEurope PMCCrossref
  2. Surgical Treatment of Congenital Facial Palsy: A Retrospective Analysis of More than 20 Years’ Experience in Smile Surgery
    Andrea Ferri, Giorgia Menapace, Cecilia Zannoni +4
    Medicina (Kaunas, Lithuania)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Endovascular treatment of postsurgical aortic recoarctation in a young adult with complex congenital heart disease
    Wojciech Stecko, Piotr Wańczura, Andrzej Curzytek +3
    Postepy w kardiologii interwencyjnej = Advances in interventional cardiologyPeer-reviewedCC BY-NC-SAFull textEpidemiology & public healthEurope PMCPMC
  4. Endoscopic Marsupialization of Frontal Sinus Cholesterol Granuloma via a Draf IIb Approach: A Case Report
    Yuichi Teranishi, Kenta Uemura, Kazuki Amesara +2
    CureusPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Improving Physician Orders for Life-Sustaining Treatment (POLST) Documentation Through an Age-Friendly Health Systems 4Ms What Matters Workflow in an Outpatient Geriatric Clinic
    Kourosh A Moshiri, Louis Guitron, Hyo Mun
    CureusPeer-reviewedCC BY 4.0Full textEpidemiology & public healthPMC
BibTeX
@article{caron2026clinicbased,
  title = {{Clinic‐Based Transnasal Marsupialization for the Treatment of Congenital Dacryocystocele}},
  author = {Camille Caron and Charlotte Lussier and Annie Lapointe and Rosanne Superstein and Erika Mercier},
  journal = {Otolaryngology--Head and Neck Surgery},
  year = {2026},
  month = aug,
  doi = {10.1002/ohn.70372},
  url = {https://doi.org/10.1002/ohn.70372},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - Clinic‐Based Transnasal Marsupialization for the Treatment of Congenital Dacryocystocele
AU  - Camille Caron
AU  - Charlotte Lussier
AU  - Annie Lapointe
AU  - Rosanne Superstein
AU  - Erika Mercier
PY  - 2026
DA  - 2026/08/17
JO  - Otolaryngology--Head and Neck Surgery
DO  - 10.1002/ohn.70372
UR  - https://doi.org/10.1002/ohn.70372
AB  - Objective: To evaluate the feasibility and outcomes of endoscopic intranasal marsupialization as treatment for congenital dacryocystocele, performed under topical anesthesia in a clinical setting.  Study Design: A retrospective review was conducted at a tertiary pediatric care hospital spanning from 2014 to 2024.  Setting: 23 infants under 1 year of age who underwent marsupialization under topical anesthesia for the treatment of a dacryocystocele were identified and their medical records were analyzed. No control group was used for this study.  Methods: Through a review of patient's medical files, the surgical technique used for cases of marsupialization under topical anesthesia in our medical center was documented and described.  Results: The primary outcome was the success rate of marsupialization procedures under topical anesthesia, defined as nonrecurrence. Secondary outcomes comprised periprocedural and postprocedure complications. The age of the patients at diagnosis ranged from 7.1 to 16.4 days. Among the 23 patients, 19 (83%) had previously failed conservative treatment before undergoing surgical intervention. Two patients (9%) experienced recurrent dacryocystocele. There were no perioperative or postoperative complications observed. Following the procedure, the most prevalent persistent symptom was nasal congestion, observed in 4 patients (17%). The mean time to treatment was 4.4 days and the overall hospital duration post‐procedure was 0.4 days.  Conclusion: This study underscores the efficacy and safety of clinic‐based endoscopic intranasal marsupialization for treating dacryocystocele. This approach expedites surgical care, eliminates the requirement for general anesthesia and allows a reduced hospital stay, making it a favorable treatment option in clinical practice.
SN  - 0194-5998
SN  - 1097-6817
ER  -